Technetium-99m labeling of antibodies has been suboptimal because of low affinity adventitious binding, nonspecific labeling, and loss of immunoreactivity. The diamide dithiolate ligand system (N2S2) forms highly stable, well-defined tetradentate complexes with Tc(V). Antibodies and their fragments have been labeled by conjugation of preformed "mTc4,5-bis(thioacetamido)pentanoate active ester to protein amine groups to give a chemically known 99"Tc-N2S2 complex covalently linked to antibody. Evaluations of the "'Tc-N2S2-bound antibodies and their fragments have shown high stability and retained immunoreactivity.
99"Tc-N2S2 complex covalently linked to antibody. Evaluations of the "'Tc-N2S2-bound antibodies and their fragments have shown high stability and retained immunoreactivity.
Successful targeting ofdiagnostic radionuclides to tumors not only provides a tool to diagnose and stage cancer but also demonstrates feasibility for therapy where ligand systems can be applied to therapy radionuclides. Early studies with radiolabeled antibodies utilized radioiodine (1231/1311) because of extensive experience in protein radioiodination, covalent attachment, and ready availability of the radionuclide (1, 2) . Improved tumor-to-nontumor ratios were achieved with 1"'In compared to 131I by using diethylenetriaminepentaacetate (DTPA) bifunctional chelating agent technology (3) (4) (5) . 1311 and 1"'In have long half-lives of 8 days and 67 hr, respectively. Recent studies utilizing antibody fragments have shown that tumor uptake and background tissue clearance can take place more rapidly with fragments, allowing the use of shorter half-life radionuclides such as 99mTc (6) .
99mTc is the ideal diagnostic single-photon radionuclide with a 6-hr half-life, 140 keV 'y radiation, no particulate radiation, and inexpensive, convenient availability. These attributes allow the routine administration of doses of 30 mCi (1 Ci = 37 GBq) that result in high photon-flux levels facilitating lesion detection by single-photon-emission computerized tomography. Despite these attractive aspects, the numerous oxidation levels available and the proclivity of 99mTc for nonspecific binding to proteins preclude easy adaptation to antibody labeling processes developed for other radionuclides such as 1"'in.
Antibodies have been labeled with "mTc both directly and through, bifunctional chelating agents, but with suboptimal results. Direct labeling involves metal binding to donor atoms on the protein, resulting in multiple binding sites of low metal affinity (7) . Bifunctional chelating agents, including DTPA (8, 9) and bis(semithiocarbazones) (10), have been studied for 99mTc labeling but have been found to suffer from problems of (i) nonspecific uptake because of the requirement for several ligands per antibody, (ii) adventitious binding of the metal to the protein, (iii) formation and binding of colloids to the antibody (11) , (iv) control of the oxidation level ofTc, and (v) low yields of specifically bound "mTc (9) .
We have applied a diamide dithiolate ligand system (N2S2)
to "mTc labeling of antibody fragment. This ligand system forms highly stable tetradentate complexes with Tc (CmTc-N2S2) at the +5 oxidation level (12) . Studies of a large number of compounds containing the N2S2 donor group showed that high yields of "mTc complexes of the predicted structure were obtained (13) . We have shown that other potential metal-binding groups, such as the carboxylate group present in the N2S2 ligands, do not participate in metal binding (14) . This property enables labeling of antibody by formation of the technetium complex, then chemical conversion of the carboxylate group to an active ester, and finally conjugation of the preformed complex to antibody. Preliminary results of studies of this approach were included in a review of 99mTc labeling of antibodies (15) .
MATERIALS AND METHODS Preparation of 99mTc-4,5-bis(thioacetamido)pentanoyl (N2S2)-Conjugated Anti-Melanoma 9.2.27 F(ab')2 Fragment. To a mixture of 25 1.l of 4,5-bis(benzoylthioacetamido)pentanoic acid (1.0 mg/ml solution in 90% CH3CN) and 100 ,ul of 1 M NaOH was added 100 mCi of sodium [99mTc]pertechnetate in 1.0 ml of saline (0.9% NaCl). Then 1.0 mg of sodium dithionite (0.10 ml of a freshly prepared 10 mg/ml solution) was added, and the mixture was heated at 750C for 15 min.
The pH was brought to about 6 with 0.10 ml of 1 M HCI and 0.30 ml of 0.2 M sodium phosphate buffer (pH 6.0). Then 10.0 mg of 2,3,5,6-tetrafluorophenol (0.10 ml of a 100 mg/ml solution in 90% CH3CN) and 12.5 mg of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (0.10 ml of a 125.0 mg/ml solution in 90% CH3CN) were added, and the solution was heated at 75°C for 30 min. The resulting tetrafluorophenyl active ester derivative of "mTc-4,5-bis(thioacetamido)pentanoate was purified by loading the reaction mixture on a conditioned C18 cartridge (J. T. Baker), washing with 2.0 ml of 20% (vol/vol) ethyl alcohol/0.01 M sodium phosphate, pH 7.0, eight times, and eluting with 100% CH3CN. The solvent was evaporated under a stream of N2. Then 0.5 ml of the 9.2.27 F(ab')2 fragment (16) at 2.5 mg/ml and 0.50 ml of 0.2 M sodium phosphate (pH 9.0) were added for conjugation. After 15 min at room temperature, 25 mg of lysine (0.25 ml of a 250-mg/ml solution at pH 9.0) was added to quench unreacted ester. The 99mTc-N2S2-9.2.27 F(ab')2 was purified by passage through a G-25 Sephadex column (Pharmacia) equilibrated with phosphate-buffered saline.
Abbreviations: N2S2, diamide dithiolate chelating system; 99M Tc-N2S2-9.2.27 F(ab')2, 99mTc-4,5-bis(thioacetamido)pentanoyl-9.2.27 F(ab')2 fragments; DPTA, diethylenetriaminepentaacetate. *To whom reprint requests should be addressed.
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. An idiotypic antibody (NR-2-AD) specific to an individual's human B-cell lymphoma (17) was used in F(ab')2 form as a control antibody for the in vivo biodistribution studies. It was labeled as described for 9.2.27 F(ab')2.
Evaluation of ""'Tc-N2S2-9.2.27 F(ab')2 Stability. The stability of the 9'9Tc binding to the antibody fragment was tested by incubation at 37TC in the presence of various challenge agents, including human serum, 10 mM DTPA, 10 mM 2,3-bis(thioacetamido)propanoate, and 6 M urea. Samples were removed at various times and analyzed by HPLC, isoelectric focusing electrophoresis, and NaDodSO4/PAGE.
Radiolabeled Cell Binding Assay. The immunoreactivity of "mTc-N2S2-9.2.27 F(ab')2 was assessed in an antigen-excess cell binding assay (18 of three and six mice, respectively, with 9'9Tc-labeled F(ab')2 fragments of melanoma-specific 9.2.27 antibody and nonspecific NR-2-AD antibody. Tumor weights were 335 mg + 185 SD for the 9.2.27 F(ab')2 biodistribution and 222 + 67 mg for the NR-2-AD F(ab')2. Tumor weights were 619 mg for the 9.2.27 F(ab')2 and 543 mg (range, 543-720 mg) for the NR-2-AD F(ab')2 imaging studies. Imaged mice each received 50 ,ug of protein labeled with 1-1.5 mCi in an intravenous administration of 100 ,u via the tail vein. Mice were imaged serially for 16 hr after injection with a smallfield-of-view (200 mm) scintillation camera (General Electric). In the biodistribution studies, mice each received 10 ,ug of protein labeled with 100 uCi in an intravenously administered dose of 100 ,ul. The animals were sacrificed 20 hr after injection; blood, tumor, tail (injection site), skin, heart, bone, lung, liver, spleen, stomach, neck (thyroid), kidneys, and intestine were isolated, blotted when appropriate, weighed, and assayed in a crystal scintillation detector well counter. Mean percent injected dose per g of body weight was calculated by comparison with radioactivity of standard samples of injectate. (Fig. 1) . HPLC chromatograms of carboxylate and active ester forms of the Tc complex are shown in Fig. 2 . The reduced polarity of the ester allowed purification by a low-pressure reversed-phase cartridge system. Conjugation to antibody lysine amino groups was carried out by addition of anti-melanoma 9.2.27 F(ab')2 and buffer to adjust the pH to 9.0. HPLC chromatograms ofcrude product and 'mTc-N2 S2-9.2.27 F(ab')2 after gel filtration purification are shown in Fig. 3 . The yields of the carboxylate form of the complex were essentially quantitative. The ester yields were about 70%. Conjugation yields ranged from 50% to 70%o. Thus, overall yields were about 35% to 50%. Total time for the procedure was about 3 hr.
Support for the aminoacylation reaction to give an amide conjugate was provided by pH dependency of the reaction (Fig. 4) . The yield of 'Tc-labeled antibody was low at neutral pH and increased as the pH increased in a manner expected for reaction-rate acceleration because of increased availability of deprotonated amino groups. Routinely, conjugations were run at pH 9 as a trade-off between yield and concern for maintaining mild conditions with respect to the relatively unstable F(ab')2 fragments.
The stability of the 99mTc label was evaluated by challenge under several conditions. These included human serum, chelating agents 10 mM DTPA and 10 mM 2,3-bis(thioace- 3 . HPLC chromatograms of starting 9.2.27 F(ab')2 (spectrophotometric trace in A), crude 9'Tc conjugation product (radiometric trace in B), and purified 9I1Tc-N2S2-9.2.27 F(ab')2 (radiometric trace in C). The column used was Zorbax GF-250 (DuPont). Conditions Tc-N2S2 F (ab' ) 2 9 9 serum and F2S2F(ab')2
Proc. Nail. Acad. antibody F(ab')2, corresponding radioactivity of 991Tc-N2S2-conjugated F(ab')2, and a sample [lanes serum and 9'Tc-N2S2-F(ab')2] in which the preparation was mixed 1:1 with serum. The shift in the autoradiography bands compared to protein staining can be attributed to the minus charge associated with the Tc complex. The isoelectric focusing was wide-gradient pH 3.5-9.5 in a 0.5-mm thick agarose gel (0.9% Isogel, LKB) containing 2.5% (wt/vol) Ampholines (LKB) and 10% sorbitol. Samples applied were 10 ,g of 9.2.27 F(ab')2 and 1:1 serum and labeled F(ab')2 diluted 1:9 with phosphate-buffered saline before application. Volumes were 15 A.l. Specific activity of labeled F(ab')2 was 6.9 mCi/mg, and concentration was 1.8 mg/ml. comparable or better than that found with previous labeling methodologies using 9.2.27-e.g., 68% for "'In-DTPAconjugated (21) and 59% for 1251I and 1311-labeled by the chloramine-T method (22) . Cell binding immunoreactivity of 99mTc-N2S2-9.2.27 F(ab')2 was 74 ± 4.9% (11 preparations (24) .
Rhenium has virtually identical structural properties in its complexes compared to Tc (25) . We have demonstrated this with penicillamine, an N,S ligand (26) . Application of the N2S2-metal complex conjugation technology for radiotherapy is thus apparent from these studies, since isotopes of rhenium, "8Re and "mRe, have favorable therapy properties because oftheir radiations. Preliminary studies of '"Re and 18Re indicate that the same N2S2 diamide dithiolate technology is applicable to the rhenium labeling of proteins and gives biodistribution properties that are virtually identical to those of 99mTc (27) .
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